BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 8685015)

  • 1. [Pertussis. Critical revision of its physiopathology. Implications].
    Fiore D
    Pediatr Med Chir; 1996; 18(1):109-12. PubMed ID: 8685015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Population dynamics of Bordetella pertussis in Finland and Sweden, neighbouring countries with different vaccination histories.
    Elomaa A; Advani A; Donnelly D; Antila M; Mertsola J; He Q; Hallander H
    Vaccine; 2007 Jan; 25(5):918-26. PubMed ID: 17030495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evolution of Bordetella pertussis.
    He Q
    Pediatr Infect Dis J; 2016 Aug; 35(8):915-7. PubMed ID: 27213264
    [No Abstract]   [Full Text] [Related]  

  • 4. Changes of the Swedish Bordetella pertussis population in incidence peaks during an acellular pertussis vaccine period between 1997 and 2004.
    Advani A; Donnelly D; Gustafsson L; Hallander HO
    APMIS; 2007 Apr; 115(4):299-310. PubMed ID: 17504296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pertussis control: time for something new?
    Clark TA; Messonnier NE; Hadler SC
    Trends Microbiol; 2012 May; 20(5):211-3. PubMed ID: 22494804
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological types of whooping cough bacteria and their connection with immunity in vaccinated children.
    Demina AA; Devyatkina NP; Voloshina LZ; Larina LI; Semina NA; Venglinskaya EA; Kostyukova KP
    J Hyg Epidemiol Microbiol Immunol; 1973 Mar; 17(3):304-15. PubMed ID: 4355335
    [No Abstract]   [Full Text] [Related]  

  • 7. Dynamics of transplacental transmission of pertussis antibodies in premature and full-term infants.
    Nomura M; Kuno-Sakai H; Kimura M; Ichikawa I
    Tokai J Exp Clin Med; 2003 Apr; 28(1):21-6. PubMed ID: 12880300
    [No Abstract]   [Full Text] [Related]  

  • 8. Using computer simulations to compare pertussis vaccination strategies in Australia.
    Hethcote HW; Horby P; McIntyre P
    Vaccine; 2004 Jun; 22(17-18):2181-91. PubMed ID: 15149775
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should fimbriae be included in pertussis vaccines? Studies on ELISA IgG anti-Fim2/3 antibodies after vaccination and infection.
    Hallander HO; Ljungman M; Jahnmatz M; Storsaeter J; Nilsson L; Gustafsson L
    APMIS; 2009 Sep; 117(9):660-71. PubMed ID: 19703126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Monitoring of a whooping cough epidemic 1994/95 in Switzerland using the sentinel notification system. Sentinella Registry].
    Matter HC; Schmidt-Schläpfer G; Zimmermann H
    Schweiz Med Wochenschr; 1996 Aug; 126(34):1423-32. PubMed ID: 8848704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum IgG antibody response to pertussis toxin in persons for whom pertussis vaccination failed depends upon the number of antigens in the vaccine.
    Cherry JD
    Clin Infect Dis; 1999 Mar; 28(3):560-1. PubMed ID: 10194078
    [No Abstract]   [Full Text] [Related]  

  • 12. Lung pathology and immediate hypersensitivity in a mouse model after vaccination with pertussis vaccines and challenge with Bordetella pertussis.
    Vandebriel RJ; Gremmer ER; Vermeulen JP; Hellwig SM; Dormans JA; Roholl PJ; Mooi FR
    Vaccine; 2007 Mar; 25(12):2346-60. PubMed ID: 17224216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunogenicity of acellular pertussis vaccines using two vaccines for primary immunization.
    von König CH; Herden P; Palitzsch D; Schneeweiss B; Bier N
    Pediatr Infect Dis J; 2000 Aug; 19(8):757-9. PubMed ID: 10959748
    [No Abstract]   [Full Text] [Related]  

  • 14. A commentary on the pathogenesis of pertussis.
    Hewlett EL
    Clin Infect Dis; 1999 Jun; 28 Suppl 2():S94-8. PubMed ID: 10447025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pertussis: persistent pathogen, imperfect vaccines.
    Yeh SH
    Expert Rev Vaccines; 2003 Feb; 2(1):113-27. PubMed ID: 12901603
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Whooping cough: diagnosis, prevention].
    Ovetchkine P
    Rev Prat; 1999 May; 49(10):1107-13. PubMed ID: 10485198
    [No Abstract]   [Full Text] [Related]  

  • 17. The resurgence of pertussis: the 100-day cough.
    Mahon CR
    Clin Lab Sci; 1999; 12(5):297-301. PubMed ID: 10623328
    [No Abstract]   [Full Text] [Related]  

  • 18. Acellular pertussis vaccines: what lies ahead?
    Wiedermann BL
    Contemp Pediatr; 1995 Sep; 12(9):25-8, 30, 32 passim. PubMed ID: 10155576
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pertussis epidemics].
    Engell-Nørregård L; Hartzen S; Colding H
    Ugeskr Laeger; 2003 Oct; 165(44):4205-7. PubMed ID: 14621550
    [No Abstract]   [Full Text] [Related]  

  • 20. Genetic stability of the live attenuated Bordetella pertussis vaccine candidate BPZE1.
    Feunou PF; Ismaili J; Debrie AS; Huot L; Hot D; Raze D; Lemoine Y; Locht C
    Vaccine; 2008 Oct; 26(45):5722-7. PubMed ID: 18762220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.